Shots:
- Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes
- The system continuously measures glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high/low without scanning
- The technology sustains performance for ~14days, providing trends, insights & actionable data on a reader or with the FreeStyle LibreLink mobile app. FreeStyle Libre 2 will be available for people with diabetes aged ≥4yrs. in Canada in the coming months
Click here to read full press release/ article | Ref: PRNewswire | Image: BioSpace
The post Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes first appeared on PharmaShots.
